Quarterly report pursuant to Section 13 or 15(d)

Interim Segment Information (Tables)

v3.20.2
Interim Segment Information (Tables)
 6 Months Ended
Sep. 30, 2020
Segment Reporting [Abstract]  
Segment information
Segment information for the three and six months ended September 30, 2020, and 2019, is set forth below: 
Three months ended September 30, 2020
(in thousands) IBW ISM CNS Total
Revenue $ 3,021  $ 1,908  $ 3,391  $ 8,320 
Cost of revenue 1,987 

883  2,659  5,529 
Gross profit 1,034  1,025  732  2,791 
Gross margin 34.2  % 53.7  % 21.6  % 33.5  %
Research and development 315  404  195  914 
Segment profit $ 719  $ 621  $ 537  1,877 
Operating expenses:
Sales and marketing 1,448 
General and administrative 1,102 
Intangible amortization 225 
Operating profit (loss) (898)
Other income, net 15 
Income tax benefit (expense) (2)
Net income (loss) $ (885)
Three months ended September 30, 2019
(in thousands) IBW ISM CNS Total
Revenue $ 2,618  $ 2,646  $ 2,305  $ 7,569 
Cost of revenue 2,205  1,604  2,181  5,990 
Gross profit 413  1,042  124  1,579 
Gross margin 15.8  % 39.4  % 5.4  % 20.9  %
Research and development 403  619  427  1,449 
Segment profit (loss) $ 10  $ 423  $ (303) 130 
Operating expenses:
Sales and marketing 2,259 
General and administrative 1,249 
Intangible amortization 308 
Operating profit (loss) (3,686)
Other income, net 125 
Income tax benefit (expense) — 
Net income (loss) $ (3,561)
  Six months ended September 30, 2020
(in thousands) IBW ISM CNS Total
Revenue $ 5,970  $ 3,955  $ 5,745  $ 15,670 
Cost of revenue 3,736 

1,775  4,526  10,037 
Gross profit 2,234  2,180  1,219  5,633 
Gross margin 37.4  % 55.1  % 21.2  % 35.9  %
Research and development 664  786  409  1,859 
Segment profit $ 1,570  $ 1,394  $ 810  3,774 
Operating expenses:
Sales and marketing 2,824 
General and administrative 2,312 
Intangible amortization 451 
Operating profit (loss) (1,813)
Other income, net 45 
Income tax benefit (expense) 58 
Net income (loss) $ (1,710)
Six months ended September 30, 2019
(in thousands) IBW ISM CNS Total
Revenue $ 5,541  $ 5,741  $ 5,289  $ 16,571 
Cost of revenue 4,156  3,120  4,470  11,746 
Gross profit 1,385  2,621  819  4,825 
Gross margin 25.0  %

45.7  % 15.5  % 29.1  %
Research and development 802  1,320  883  3,005 
Segment profit (loss) $ 583  $ 1,301  $ (64) 1,820 
Operating expenses:
Sales and marketing 4,591 
General and administrative 2,613 
Intangible amortization 616 
Operating profit (loss) (6,000)
Other income, net 289 
Income tax benefit (expense) (7)
Net income (loss) $ (5,718)